68Ga-LNC1007
Oncology (Target not specified)
Phase 1Active (initiating)
Key Facts
Indication
Oncology (Target not specified)
Phase
Phase 1
Status
Active (initiating)
Company
About Yantai LNC Biotechnology
A clinical-stage biotech developing innovative radiopharmaceuticals for cancer theranostics, backed by Dongcheng Pharmaceutical Group.
View full company profile